Signet Investment Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.28M | Buy |
135,312
+3,194
| +2% | +$77.4K | 1.68% | 23 |
|
|
2025
Q1 | $3.35M | Buy |
132,118
+8,932
| +7% | +$226K | 1.69% | 22 |
|
|
2024
Q4 | $3.27M | Buy |
123,186
+4,152
| +3% | +$110K | 1.67% | 23 |
|
|
2024
Q3 | $3.44M | Buy |
119,034
+2,507
| +2% | +$72.6K | 1.72% | 21 |
|
|
2024
Q2 | $3.26M | Buy |
116,527
+3,915
| +3% | +$110K | 1.75% | 20 |
|
|
2024
Q1 | $3.12M | Buy |
112,612
+6,500
| +6% | +$180K | 1.71% | 22 |
|
|
2023
Q4 | $3.05M | Buy |
106,112
+4,045
| +4% | +$116K | 1.84% | 18 |
|
|
2023
Q3 | $3.39M | Buy |
102,067
+2,260
| +2% | +$75K | 2.25% | 15 |
|
|
2023
Q2 | $3.66M | Buy |
99,807
+1,344
| +1% | +$49.3K | 2.42% | 12 |
|
|
2023
Q1 | $4.02M | Buy |
98,463
+8,196
| +9% | +$334K | 2.77% | 7 |
|
|
2022
Q4 | $4.63M | Sell |
90,267
-593
| -0.7% | -$30.4K | 3.26% | 6 |
|
|
2022
Q3 | $3.98M | Buy |
90,860
+386
| +0.4% | +$16.9K | 3.08% | 7 |
|
|
2022
Q2 | $4.74M | Sell |
90,474
-1,869
| -2% | -$98K | 3.29% | 6 |
|
|
2022
Q1 | $4.78M | Sell |
92,343
-2,535
| -3% | -$131K | 2.87% | 6 |
|
|
2021
Q4 | $5.6M | Buy |
94,878
+22
| +0% | +$1.3K | 3.19% | 6 |
|
|
2021
Q3 | $4.08M | Buy |
94,856
+4,504
| +5% | +$194K | 2.57% | 8 |
|
|
2021
Q2 | $3.54M | Buy |
90,352
+5,703
| +7% | +$223K | 2.28% | 10 |
|
|
2021
Q1 | $3.07M | Buy |
84,649
+2,411
| +3% | +$87.4K | 2.38% | 12 |
|
|
2020
Q4 | $3.03M | Buy |
+82,238
| New | +$3.03M | 2.39% | 11 |
|
|
2019
Q4 | $2.45M | Buy |
65,946
+480
| +0.7% | +$17.8K | 2.28% | 14 |
|
|
2019
Q3 | $2.23M | Sell |
65,466
-1,459
| -2% | -$49.7K | 2.27% | 16 |
|
|
2019
Q2 | $2.75M | Sell |
66,925
-3,316
| -5% | -$136K | 2.87% | 9 |
|
|
2019
Q1 | $2.83M | Sell |
70,241
-372
| -0.5% | -$15K | 3.01% | 7 |
|
|
2018
Q4 | $2.92M | Buy |
+70,613
| New | +$2.92M | 3.28% | 6 |
|